The DIAMOND Study: Distensibility Improvement And Remodeling in Diastolic Heart Failure
A Pilot Study Of ALT-711 In Elderly Patients With Isolated Diastolic Heart Failure: The DIAMOND Study
Sponsor: Synvista Therapeutics, Inc
This PHASE2 trial investigates Dyspnea and Heart Failure, Congestive and is currently completed. Synvista Therapeutics, Inc leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jul 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Synvista Therapeutics, Inc
For direct contact, visit the study record on ClinicalTrials.gov .